CoChat

Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription

Open access

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Elevated serum levels of triglyceride-rich remnant lipoproteins (TRL) are a major risk factor predisposing a subject to atherosclerosis. Apolipoprotein C-III (apoC-III) is a major constituent of TRL that impedes triglyceride hydrolysis and remnant clearance and, as such, may exert pro-atherogenic activities. In the present study, transient cotransfection experiments in rat hepatocytes in primary culture and rabbit kidney RK13 cells demonstrated that overexpression of Rev-erbalpha specifically decreases basal and HNF-4 stimulated human apoC-III promoter activity. A Rev-erbalpha response element was mapped by promoter deletion, mutation analysis, and gel-shift experiments to a AGGTCA half-site located at position -23/-18 (downstream of the TATA box) in the apoC-III promoter. Finally, Rev-erbalpha-deficient mice displayed elevated serum and liver mRNA levels of apoC-III together with increased serum VLDL triglycerides. Taken together, our data identify Rev-erbalpha as a regulator of apoC-III gene expression, providing a novel, physiological role for this nuclear receptor in the regulation of lipid metabolism.

Overview

Integrity signals

Registry

Crossref · 10.1194/jlr.m200386-jlr200

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 51 references

Cited by

See all 189

Metadata

Authors
Raspé, E., Duez, H., Mansén, A., Fontaine, C., Fiévet, C., Fruchart, J.-C., Vennström, B., & Staels, B.
Affiliations
  • Inserm (FR)
  • Karolinska Institutet (SE)
Corresponding author
Staels, Bart
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2002-12
Volume
43
Issue
12
Pages
2172-2179
ISSN
0022-2275 (ISSN-L)
OpenAlex
W1983841082
Cited by
183
References
51
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 14 · 2020: 12 · 2019: 3 · 2018: 4 · 2017: 9 · 2016: 2 · 2015: 8 · 2014: 11 · 2013: 12 · 2012: 12
FWCI
1.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
NR1D1, apolipoprotein C-III, transcriptional repression, atherosclerosis, HNF4, promoter regulation, VLDL triglycerides, lipid metabolism, hepatocytes
MeSH terms
Animals, Apolipoproteins C, DNA-Binding Proteins, Gene Expression Regulation, Humans, Male, Mice, Inbred BALB C, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Cholesterol, VLDL, Receptors, Cytoplasmic and Nuclear, Hepatocytes, Mice, Rats, Apolipoprotein C-III, Nuclear Receptor Subfamily 1, Group D, Member 1, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription. https://app.cochat.ai/papers/10.1194/jlr.m200386-jlr200
The paper
Raspé, E., Duez, H., Mansén, A., Fontaine, C., Fiévet, C., Fruchart, J.-C., Vennström, B., & Staels, B. (2002). Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription. Journal of Lipid Research. https://doi.org/10.1194/jlr.m200386-jlr200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.